The HIV-1 gp120 V1V2 loop: structure, function and importance for vaccine development
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The HIV-1 gp120 V1V2 loop: structure, function and importance for vaccine development
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 13, Issue 12, Pages 1489-1500
Publisher
Informa UK Limited
Online
2014-08-28
DOI
10.1586/14760584.2014.951335
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Implications of the Binding Mode of a Human Conformation-Dependent V2 Monoclonal Antibody against HIV
- (2014) B. Spurrier et al. JOURNAL OF VIROLOGY
- HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities
- (2014) Justin Pollara et al. JOURNAL OF VIROLOGY
- Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial
- (2014) A. J. Gartland et al. JOURNAL OF VIROLOGY
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
- (2014) Nicole A. Doria-Rose et al. NATURE
- Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
- (2014) Susan Zolla-Pazner et al. PLoS One
- Soluble HIV-1 Envelope Immunogens Derived from an Elite Neutralizer Elicit Cross-Reactive V1V2 Antibodies and Low Potency Neutralizing Antibodies
- (2014) Sara Carbonetti et al. PLoS One
- Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
- (2014) A. W. Chung et al. Science Translational Medicine
- Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
- (2014) N. L. Yates et al. Science Translational Medicine
- Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
- (2013) Dan H. Barouch et al. CELL
- Epitope Specificity of Human Immunodeficiency Virus-1 Antibody Dependent Cellular Cytotoxicity [ADCC] Responses
- (2013) Justin Pollara et al. CURRENT HIV RESEARCH
- HIV-1 Variable Loop 2 and its Importance in HIV-1 Infection and Vaccine Development
- (2013) Mangala Rao et al. CURRENT HIV RESEARCH
- The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry
- (2013) Sabrina Cardaci et al. FEBS LETTERS
- Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
- (2013) Hua-Xin Liao et al. IMMUNITY
- Early Infection HIV-1 Envelope V1-V2 Genotypes Do Not Enhance Binding or Replication in Cells Expressing High Levels of α4β7 Integrin
- (2013) Behzad Etemad et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Overcoming Current Limitations in Humanized Mouse Research
- (2013) Michael A. Brehm et al. JOURNAL OF INFECTIOUS DISEASES
- Multiple Pathways of Escape from HIV Broadly Cross-Neutralizing V2-Dependent Antibodies
- (2013) P. L. Moore et al. JOURNAL OF VIROLOGY
- Infectious Virion Capture by HIV-1 gp120-Specific IgG from RV144 Vaccinees
- (2013) P. Liu et al. JOURNAL OF VIROLOGY
- The Canarypox Virus Vector ALVAC Induces Distinct Cytokine Responses Compared to the Vaccinia Virus-Based Vectors MVA and NYVAC in Rhesus Monkeys
- (2013) J. E. Teigler et al. JOURNAL OF VIROLOGY
- Molecular Evolution of the HIV-1 Thai Epidemic between the Time of RV144 Immunogen Selection to the Execution of the Vaccine Efficacy Trial
- (2013) G. H. Kijak et al. JOURNAL OF VIROLOGY
- Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV
- (2013) Mario Roederer et al. NATURE
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
- (2013) Scott M. Hammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
- (2013) Susan Zolla-Pazner et al. PLoS One
- HIV-1 Envelope Glycoprotein Variable Loops Are Indispensable for Envelope Structural Integrity and Virus Entry
- (2013) Tingting Yuan et al. PLoS One
- Serum Cytokine Profiles Associated with Specific Adjuvants Used in a DNA Prime-Protein Boost Vaccination Strategy
- (2013) Rachel Buglione-Corbett et al. PLoS One
- Epitope Mapping of Conformational V2-specific Anti-HIV Human Monoclonal Antibodies Reveals an Immunodominant Site in V2
- (2013) Luzia M. Mayr et al. PLoS One
- Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
- (2013) Raphael Gottardo et al. PLoS One
- Phenotypic properties of transmitted founder HIV-1
- (2013) N. F. Parrish et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
- (2013) G. D. Tomaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
- (2013) J.-P. Julien et al. SCIENCE
- A brief history of the global effort to develop a preventive HIV vaccine
- (2013) José Esparza VACCINE
- Specific sequences commonly found in the V3 domain of HIV-1 subtype C isolates affect the overall conformation of native Env and induce a neutralization-resistant phenotype independent of V1/V2 masking
- (2013) Aidy Salomon et al. VIROLOGY
- Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes
- (2013) Constantinos Kurt Wibmer et al. PLoS Pathogens
- The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120
- (2012) Nicos Karasavvas et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Nomenclature for Immune Correlates of Protection After Vaccination
- (2012) S. A. Plotkin et al. CLINICAL INFECTIOUS DISEASES
- The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope
- (2012) M. S. de Souza et al. JOURNAL OF IMMUNOLOGY
- Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus Clearance and Long-term Clinical Protection
- (2012) Yiu-Wing Kam et al. JOURNAL OF INFECTIOUS DISEASES
- Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design
- (2012) Mattia Bonsignori et al. JOURNAL OF VIROLOGY
- Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
- (2012) M. Bonsignori et al. JOURNAL OF VIROLOGY
- Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion
- (2012) S. Munir Alam et al. JOURNAL OF VIROLOGY
- A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies
- (2012) N. A. Doria-Rose et al. JOURNAL OF VIROLOGY
- Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIVmac251Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial
- (2012) Poonam Pegu et al. JOURNAL OF VIROLOGY
- HIV-1 gp120 Vaccine Induces Affinity Maturation in both New and Persistent Antibody Clonal Lineages
- (2012) M. A. Moody et al. JOURNAL OF VIROLOGY
- Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
- (2012) Morgane Rolland et al. NATURE
- Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
- (2012) Dan H. Barouch et al. NATURE
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Monoclonal Antibodies to the V2 Domain of MN-rgp120: Fine Mapping of Epitopes and Inhibition of α4β7 Binding
- (2012) Gerald R. Nakamura et al. PLoS One
- Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals
- (2012) Miroslaw K. Gorny et al. VIROLOGY
- Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
- (2011) Peter Rusert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: A Case Study for Statistical Issues in Efficacy Trials
- (2011) P. B. Gilbert et al. JOURNAL OF INFECTIOUS DISEASES
- The V1V2 Domain and an N-Linked Glycosylation Site in the V3 Loop of the HIV-1 Envelope Glycoprotein Modulate Neutralization Sensitivity to the Human Broadly Neutralizing Antibody 2G12
- (2011) A. Chaillon et al. JOURNAL OF VIROLOGY
- An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum
- (2011) G. Ferrari et al. JOURNAL OF VIROLOGY
- Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
- (2011) M. Bonsignori et al. JOURNAL OF VIROLOGY
- Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop
- (2011) P. L. Moore et al. JOURNAL OF VIROLOGY
- Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies
- (2011) M. J. van Gils et al. JOURNAL OF VIROLOGY
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
- (2011) Jason S. McLellan et al. NATURE
- Expression of HLA Class II Molecules in Humanized NOD.Rag1KO.IL2RgcKO Mice Is Critical for Development and Function of Human T and B Cells
- (2011) Rebecca Danner et al. PLoS One
- Polymorphisms in the α4 Integrin of Neotropical Primates: Insights for Binding of Natural Ligands and HIV-1 gp120 to the Human α4β7
- (2011) Mirela Darc et al. PLoS One
- Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections
- (2011) S. Gnanakaran et al. PLoS Pathogens
- The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7+/CD4+ T cells As Key Targets in Mucosal Transmission
- (2011) Fatima Nawaz et al. PLoS Pathogens
- IgG Subclass Profiles in Infected HIV Type 1 Controllers and Chronic Progressors and in Uninfected Recipients of Env Vaccines
- (2010) Kaustuv Banerjee et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Blocking of 4 7 Gut-Homing Integrin during Acute Infection Leads to Decreased Plasma and Gastrointestinal Tissue Viral Loads in Simian Immunodeficiency Virus-Infected Rhesus Macaques
- (2010) A. A. Ansari et al. JOURNAL OF IMMUNOLOGY
- Mutation at a Single Position in the V2 Domain of the HIV-1 Envelope Protein Confers Neutralization Sensitivity to a Highly Neutralization-Resistant Virus
- (2010) S. M. O'Rourke et al. JOURNAL OF VIROLOGY
- Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users
- (2010) K. J. Bar et al. JOURNAL OF VIROLOGY
- Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
- (2010) Davide Corti et al. PLoS One
- Single-particle cryoelectron microscopy analysis reveals the HIV-1 spike as a tripod structure
- (2010) S.-R. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Architectures of Trimeric SIV and HIV-1 Envelope Glycoproteins on Intact Viruses: Strain-Dependent Variation in Quaternary Structure
- (2010) Tommi A. White et al. PLoS Pathogens
- HIV-1 Envelope Subregion Length Variation during Disease Progression
- (2010) Marcel E. Curlin et al. PLoS Pathogens
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
- (2009) L. M. Walker et al. SCIENCE
- Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways
- (2009) Rong Rong et al. PLoS Pathogens
- Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1
- (2009) Richard E. Haaland et al. PLoS Pathogens
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- (2008) Alexandre Harari et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
- HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells
- (2008) James Arthos et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now